{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T06:17:28Z","timestamp":1675145848814},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2016,11,9]]},"DOI":"10.2174\/1381612822666160607220532","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T07:56:35Z","timestamp":1466150195000},"page":"5057-5064","source":"Crossref","is-referenced-by-count":5,"title":["De Novo Design of New Inhibitor of Mutated Tyrosine-Kinase for the Myeloid Leukemia Treatment"],"prefix":"10.2174","volume":"22","author":[{"given":"Washington","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihosvany","family":"Camps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/143097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T11:05:21Z","timestamp":1479467121000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=22&issue=33&spage=5057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":0,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2016,11,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612822666160607220532","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}